Hofseth Biocare
Hofseth Biocare ASA, commonly referred to as Hofseth Biocare, is a leading player in the biotechnology and health supplement industry, headquartered in Norway. Founded in 2009, the company has established itself as a pioneer in the development of high-quality marine ingredients, focusing on sustainable practices and innovative extraction methods. With operations primarily in Norway and a growing presence in international markets, Hofseth Biocare offers a range of unique products, including omega-3 fatty acids, collagen peptides, and other bioactive compounds derived from fish. Their commitment to sustainability and quality has positioned them as a trusted supplier in the health and wellness sector, earning recognition for their advanced research and development initiatives. As a result, Hofseth Biocare continues to make significant strides in promoting health through marine biotechnology.
DitchCarbon Score
How does Hofseth Biocare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hofseth Biocare's score of 31 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hofseth Biocare's reported carbon emissions
In 2024, Hofseth Biocare reported total carbon emissions of approximately 14,930,000 kg CO2e. This figure includes Scope 1 emissions of about 1,616,000 kg CO2e, Scope 2 emissions of approximately 48,000 kg CO2e, and Scope 3 emissions, which comprise upstream transportation and distribution at about 445,000 kg CO2e and downstream transportation and distribution at approximately 1,453,000 kg CO2e. Comparatively, in 2023, the company recorded total emissions of about 21,548,749 kg CO2e, with Scope 1 emissions at approximately 1,850,000 kg CO2e and Scope 2 emissions at around 46,000 kg CO2e. This indicates a significant reduction in total emissions from 2023 to 2024. Hofseth Biocare has not set specific reduction targets under the Science Based Targets initiative (SBTi) nor does it have documented climate pledges. The company’s emissions data is self-reported and does not cascade from a parent organization, indicating that it operates independently in its climate reporting. Overall, Hofseth Biocare is actively monitoring its carbon footprint, with a focus on reducing emissions across all scopes, although specific reduction initiatives or targets have not been disclosed.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 1,619,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 90,400 | 00,000 | 00,000 | 00,000 | 00,000 |
| Scope 3 | - | - | - | - | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hofseth Biocare is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
